Adamis Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Adamis Pharmaceuticals
Q3 2023
14 Nov, 2023
Q2 2023
21 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adamis Pharmaceuticals Corporation
Access all reports
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing therapeutic products in allergy, respiratory, and opioid overdose treatment. Its portfolio includes prescription medicines and drug-device combination products, such as epinephrine injectors for severe allergic reactions and naloxone for opioid overdose reversal. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
ADMP
Country
🇺🇸 United States